Anest. intenziv. Med. 2020;31(6):310-311 | DOI: 10.36290/aim.2020.064

Use of corticosteroids in COVID-19New guidelines

Balík M.1, Votruba J.2, Matějovič M.3, Suk P.4, ©rámek V.4
1 Klinika anesteziologie, resuscitace a intenzivní medicíny 1. LF UK a VFN v Praze
2 I. klinika tuberkulózy a respiračních nemocí medicíny 1. LF UK a VFN v Praze
3 I. interní klinika LF UK a FN Plzeň
4 Anesteziologicko resuscitační klinika, FNUSA Brno

Published: December 30, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balík M, Votruba J, Matějovič M, Suk P, ©rámek V. Use of corticosteroids in COVID-19. Anest. intenziv. Med. 2020;31(6):310-311. doi: 10.36290/aim.2020.064.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Prescott HC, Rice TW. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic. Jama 2020. Go to original source...
    2. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta‑analysis. Jama 2020.
    3. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. The New England journal of medicine 2020. Go to original source...
    4. Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of Dexamethasone on Days Alive and Ventilator‑Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. Jama 2020. Go to original source...
    5. Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double‑Blind, Phase IIb, Placebo‑Controlled Trial. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2020.
    6. Angus DC, Derde L, Al‑Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP‑CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. Jama 2020.
    7. Dequin PF, Heming N, Meziani F, Plantefève G, Voiriot G, Badié J, et al. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. Jama 2020. Go to original source...
    8. Cain DW, Cidlowski JA. After 62 years of regulating immunity, dexamethasone meets COVID-19. Nature reviews Immunology 2020; 20(10): 587-588. Go to original source... Go to PubMed...
    9. Lu X, Chen T, Wang Y, Wang J, Yan F. Adjuvant corticosteroid therapy for critically ill patients with COVID-19. Critical care 2020; 24(1): 241. Go to original source... Go to PubMed...
    10. Huang R, Zhu C, Jian W, Xue L, Li C, Yan X, et al. Corticosteroid therapy is associated with the delay of SARS‑CoV-2 clearance in COVID-19 patients. European Journal of Pharmacology 2020: 173556. Go to original source... Go to PubMed...
    11. D'Ardes D, Pontolillo M, Esposito L, Masciarelli M, Boccatonda A, Rossi I, et al. Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms 2020; 8(9). Go to original source... Go to PubMed...
    12. Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, et al. Effects of early corticosteroid treatment on plasma SARS‑associated Coronavirus RNA concentrations in adult patients. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 2004; 31(4): 304-309. Go to original source... Go to PubMed...
    13. Ma Y, Zeng H, Zhan Z, Lu H, Zeng Z, He C, et al. Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China. Frontiers in pharmacology 2020; 11: 1198. Go to original source... Go to PubMed...
    14. Bos LDJ, Brodie D, Calfee CS. Severe COVID-19 Infections‑Knowledge Gained and Remaining Questions. JAMA internal medicine 2020. Go to original source... Go to PubMed...
    15. Bassetti M, Kollef MH, Timsit JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive care medicine 2020. Go to original source...
    16. Waterer GW, Rello J. Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All. Infectious diseases and therapy 2020: 1-5. Go to original source...
    17. Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta‑analysis. Annals of the rheumatic diseases 2020. Go to original source...
    18. COVID-19 News and Information. [online]. Dostupné z: https://www.era‑edta.org/en/covid-19-news‑and‑information/#toggle‑id-1
    19. Arulkumaran N, Snow TAC, Longobardo A, Brealey D, Singer M. Steroids in ARDS: more light is being shed. Intensive care medicine 2020: 1-3. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.